Financhill
Buy
85

CELJF Quote, Financials, Valuation and Earnings

Last price:
$11.36
Seasonality move :
0.31%
Day range:
$11.36 - $11.36
52-week range:
$3.00 - $12.10
Dividend yield:
3.19%
P/E ratio:
26.38x
P/S ratio:
1.58x
P/B ratio:
2.37x
Volume:
54
Avg. volume:
876
1-year change:
120.16%
Market cap:
$1.9B
Revenue:
$1.2B
EPS (TTM):
$0.43

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Cellcom Israel Ltd. has -- downside to fair value with a price target of -- per share.

CELJF vs. S&P 500

  • Over the past 5 trading days, Cellcom Israel Ltd. has overperformed the S&P 500 by 6.73% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Cellcom Israel Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cellcom Israel Ltd. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Cellcom Israel Ltd. reported revenues of $307.2M.

Earnings Growth

  • Cellcom Israel Ltd. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter Cellcom Israel Ltd. reported earnings per share of $0.13.
Enterprise value:
2.5B
EV / Invested capital:
1.71x
Price / LTM sales:
1.58x
EV / EBIT:
22.09x
EV / Revenue:
2.10x
PEG ratio (5yr expected):
0.34x
EV / Free cash flow:
15.83x
Price / Operating cash flow:
11.88x
Enterprise value / EBITDA:
6.62x
Gross Profit (TTM):
$404.7M
Return On Assets:
4.02%
Net Income Margin (TTM):
5.98%
Return On Equity:
10.09%
Return On Invested Capital:
5.1%
Operating Margin:
11.23%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $1.2B $1.2B $1.2B $300.6M $307.2M
Gross Profit $372.1M $366.6M $404.7M $96.7M $113.3M
Operating Income $96.6M $89.4M $114.4M $25.6M $34.5M
EBITDA $335.4M $337.6M $381.6M $90.5M $105.6M
Diluted EPS $0.25 $0.24 $0.43 $0.09 $0.13
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $510.5M $545.1M $385.3M $332.8M $356.9M
Total Assets $2B $1.9B $1.7B $1.7B $1.9B
Current Liabilities $503.4M $539.2M $501.7M $541.7M $572.4M
Total Liabilities $1.4B $1.4B $1.1B $1.1B $1.1B
Total Equity $589.9M $575.8M $583.9M $643.9M $806.7M
Total Debt $1B $1B $787M $654.4M $596.6M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $297M $292.1M $344.1M $79.5M $98.2M
Cash From Investing -$146.6M -$166.1M -$180M -$44.7M -$48.5M
Cash From Financing -$234.3M -$180.4M -$184.2M -$127.4M -$97.3M
Free Cash Flow $119.5M $126M $159.7M $34.7M $49.4M
CELJF
Sector
Market Cap
$1.9B
$55.1M
Price % of 52-Week High
93.88%
64.07%
Dividend Yield
3.19%
0%
Shareholder Yield
0.04%
1.13%
1-Year Price Total Return
120.16%
-6.9%
Beta (5-Year)
0.947
0.328
Dividend yield:
3.19%
Annualized payout:
$0.00
Payout ratio:
263.22%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $11.04
200-day SMA
Buy
Level $8.24
Bollinger Bands (100)
Buy
Level 8.68 - 10.56
Chaikin Money Flow
Sell
Level -3.8M
20-day SMA
Buy
Level $10.99
Relative Strength Index (RSI14)
Buy
Level 61.57
ADX Line
Buy
Level 7.65
Williams %R
Sell
Level -15.0943
50-day SMA
Buy
Level $10.34
MACD (12, 26)
Buy
Level 0.25
25-day Aroon Oscillator
Buy
Level 12
On Balance Volume
Neutral
Level 10M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.5735)
Sell
CA Score (Annual)
Level (-0.6045)
Buy
Beneish M-Score (Annual)
Level (-3.186)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.7334)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cellcom Israel Ltd. engages in the provision of cellular communications services. It operates through two segments: Cellular and Fixed-Line. The Cellular segment includes the cellular communications services, end user cellular equipment and supplemental services. The Fixed-Line segment includes landline and long distance telephony services, internet infrastructure and connectivity services, television services, transmission services, end user fixed-line equipment and supplemental services. The company offers cellular and landline telephony, roaming, internet, fax services, text and multimedia messaging services, cellular content and data services, technical support, account information, and direct-to-the-door parcel delivery. Cellcom was founded in 1994 and is headquartered in Netanya, Israel.

Stock Forecast FAQ

In the current month, CELJF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CELJF average analyst price target in the past 3 months is --.

  • Where Will Cellcom Israel Ltd. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cellcom Israel Ltd. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Cellcom Israel Ltd.?

    Analysts are divided on their view about Cellcom Israel Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cellcom Israel Ltd. is a Sell and believe this share price will rise from its current level to --.

  • What Is Cellcom Israel Ltd.'s Price Target?

    The price target for Cellcom Israel Ltd. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CELJF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cellcom Israel Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CELJF?

    You can purchase shares of Cellcom Israel Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cellcom Israel Ltd. shares.

  • What Is The Cellcom Israel Ltd. Share Price Today?

    Cellcom Israel Ltd. was last trading at $11.36 per share. This represents the most recent stock quote for Cellcom Israel Ltd.. Yesterday, Cellcom Israel Ltd. closed at $11.36 per share.

  • How To Buy Cellcom Israel Ltd. Stock Online?

    In order to purchase Cellcom Israel Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock